Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Freehold › NPI 1295718450
Hospital

Centrastate Medical Center, INC

Centrastate Medical Center, INC was paid $47.41M by Medicaid between Jan 2018 and Dec 2024, across 246 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.

33Billing provider infoCENTRASTATE MEDICAL CENTER, INC
FREEHOLD, NJ 07728
33aNPI1295718450assigned 11/22/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$47.41M
24GClaims777,929
24DCodes billed246
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#36 of 93
Median peer was paid$30.60M
This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018102,220$6.59M
2019104,687$6.94M
202078,164$4.65M
2021105,391$6.97M
2022136,983$7.68M
2023146,081$8.53M
2024incomplete104,403$6.05M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 26% 21,049 18,527 $12.31M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 28,891 26,245 $9.77M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.2% 7,925 6,445 $4.35M
G0378 Hospital observation service, per hour 6.2% 6,525 4,763 $2.96M
J2323 Injection, natalizumab, 1 mg 5.0% 1,047 824 $2.39M
J2350 Injection, ocrelizumab, 1 mg 4.1% 221 155 $1.96M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.8% 7,025 6,391 $1.33M
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2.4% 26,995 6,990 $1.12M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.0% 32,494 8,137 $963K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 3,165 2,925 $693K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.3% 11,877 3,668 $596K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.2% 9,876 2,326 $570K
234 more codes
70450 Computed tomography, head or brain; without contrast material 1.2% 7,424 $547K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 7,572 $394K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,361 $358K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 435 $342K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 12,433 $298K
A0427 Emergency ambulance ride, advanced life support <1% 698 $264K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 40,822 $247K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 659 $244K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 13,806 $242K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,096 $205K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 973 $201K
96375 Therapeutic injection; each additional sequential IV push <1% 8,146 $196K
71046 Radiologic examination, chest; 2 views <1% 8,244 $194K
OP710 <1% 3,249 $189K
96361 Intravenous infusion, hydration; each additional hour <1% 9,743 $183K
80053 Comprehensive metabolic panel <1% 37,169 $164K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,767 $155K
OP270 <1% 19,586 $150K
OP379 <1% 1,866 $147K
97161 <1% 3,377 $144K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,173 $138K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 7,533 $137K
76830 Ultrasound, transvaginal <1% 1,300 $110K
93976 <1% 1,284 $105K
71045 Radiologic examination, chest; single view <1% 6,819 $104K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,436 $97K
99213 Doctor's office visit, returning patient (routine) <1% 2,422 $97K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,070 $91K
36415 Collection of venous blood by venipuncture <1% 36,931 $80K
71275 Computed tomographic angiography, chest, with contrast material <1% 583 $78K
OP370 <1% 1,166 $77K
97162 <1% 1,471 $76K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 9,315 $74K
97116 <1% 4,965 $73K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,054 $63K
OP272 <1% 5,830 $62K
84484 <1% 9,614 $58K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,581 $58K
81003 <1% 22,753 $56K
80048 Basic metabolic panel (calcium, ionized) <1% 6,698 $52K
OP250 <1% 40,907 $50K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,131 $47K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,415 $47K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 434 $46K
73562 <1% 1,465 $46K
90839 <1% 2,485 $43K
84443 Thyroid stimulating hormone (TSH) <1% 5,690 $42K
93971 <1% 689 $40K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,469 $40K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,302 $39K
59025 Fetal non-stress test <1% 227 $39K
74018 <1% 1,778 $38K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,715 $37K
97113 <1% 561 $37K
96415 <1% 342 $36K
85610 <1% 8,484 $35K
73630 <1% 1,386 $35K
72110 <1% 561 $33K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,234 $33K
73610 <1% 1,304 $32K
73030 <1% 1,133 $32K
85730 <1% 7,488 $32K
94060 <1% 246 $32K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 968 $32K
80061 Lipid panel <1% 4,669 $28K
A0425 Ground mileage, per statute mile <1% 708 $27K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,345 $27K
OP259 <1% 14,451 $27K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 479 $26K
87088 <1% 6,017 $26K
OP258 <1% 21,691 $25K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,083 $25K
86900 <1% 2,685 $24K
73130 <1% 728 $23K
87040 <1% 3,922 $20K
83880 <1% 2,124 $19K
87070 <1% 7,039 $19K
93970 <1% 203 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 7,067 $18K
83036 Hemoglobin; glycosylated (A1C) <1% 4,306 $18K
72125 Computed tomography, cervical spine; without contrast material <1% 237 $18K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 718 $17K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,113 $17K
83605 <1% 2,502 $16K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 718 $15K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,833 $15K
96376 <1% 1,947 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,495 $15K
82077 <1% 4,163 $15K
73110 <1% 438 $14K
83690 <1% 6,621 $14K
86850 <1% 2,376 $14K
87186 <1% 2,197 $13K
87077 <1% 2,184 $12K
99214 Doctor's office visit, returning patient (more involved) <1% 234 $12K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 729 $12K
83735 <1% 4,434 $12K
76536 <1% 113 $12K
97535 Self-care/home management training, each 15 minutes <1% 293 $11K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 12 $10K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,216 $10K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 503 $8K
73502 <1% 337 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,326 $8K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 111 $7K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 414 $7K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 310 $7K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 341 $7K
84703 <1% 4,869 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,282 $7K
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 197 $6K
72050 <1% 144 $6K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 12 $6K
94729 <1% 163 $6K
82607 <1% 1,117 $5K
86140 <1% 5,009 $5K
76642 <1% 75 $5K
85027 <1% 3,425 $5K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 17 $5K
80320 <1% 403 $5K
86769 <1% 165 $4K
J2704 Injection, propofol, 10 mg <1% 1,367 $4K
84702 <1% 902 $4K
85378 <1% 2,656 $4K
80143 <1% 1,086 $4K
84100 <1% 2,097 $4K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 81 $4K
90715 <1% 773 $4K
82150 <1% 1,959 $4K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 90 $3K
80179 <1% 1,073 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,206 $3K
12001 <1% 54 $3K
81025 <1% 2,623 $3K
74021 <1% 69 $3K
82728 <1% 679 $3K
82550 <1% 1,374 $3K
84439 <1% 843 $3K
80164 <1% 206 $3K
72100 <1% 170 $3K
86480 <1% 51 $3K
70486 <1% 33 $2K
80329 <1% 141 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 28 $2K
73590 <1% 88 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 29 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 873 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,941 $2K
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 944 $2K
85651 <1% 1,830 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 14 $2K
51701 <1% 75 $2K
93017 <1% 12 $2K
96367 <1% 203 $2K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 145 $2K
73080 <1% 84 $2K
82247 <1% 574 $2K
86901 <1% 87 $2K
86780 <1% 154 $2K
83540 <1% 603 $2K
97165 <1% 29 $2K
94726 <1% 28 $2K
86618 <1% 180 $1K
73140 <1% 127 $1K
82272 <1% 63 $1K
72070 <1% 31 $1K
83550 <1% 204 $1K
G0379 Direct admission of patient for hospital observation care <1% 303 $1K
82043 <1% 632 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 696 $1K
83518 <1% 685 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 282 $1K
76775 <1% 12 $1K
99308 Subsequent nursing facility care, per day, straightforward <1% 105 $1K
90686 <1% 156 $1K
88342 <1% 85 $1K
76870 <1% 12 $993.76
92523 <1% 12 $972.50
82746 <1% 198 $860.41
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 741 $837.09
88304 <1% 60 $797.11
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 330 $690.35
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 14 $676.45
J1170 Injection, hydromorphone, up to 4 mg <1% 851 $638.20
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 17 $636.14
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 62 $609.85
86309 <1% 387 $576.20
86665 <1% 52 $556.38
99238 Hospital discharge day management, 30 minutes or less <1% 12 $546.70
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 780 $531.33
J2060 Injection, lorazepam, 2 mg <1% 562 $488.99
83615 <1% 367 $483.81
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,475 $476.15
86803 <1% 41 $475.65
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 34 $449.70
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 12 $442.41
84550 <1% 495 $432.52
12011 <1% 14 $401.49
73090 <1% 43 $397.39
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 225 $389.68
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 221 $383.20
J1650 Injection, enoxaparin sodium, 10 mg <1% 500 $378.19
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 829 $363.83
71101 <1% 17 $330.00
82248 <1% 79 $301.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 158 $292.96
86664 <1% 52 $234.64
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 536 $210.25
J3010 Injection, fentanyl citrate, 0.1 mg <1% 918 $203.03
84480 <1% 50 $164.01
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 678 $153.26
87205 <1% 27 $146.20
87420 <1% 50 $142.80
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 5,433 $121.15
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 12 $101.51
85007 <1% 68 $99.20
83655 <1% 13 $81.90
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 13 $74.10
J1644 Injection, heparin sodium, per 1000 units <1% 207 $69.07
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 499 $44.15
81001 <1% 16 $35.94
82570 <1% 46 $34.50
81002 <1% 26 $26.00
C1769 Guide wire <1% 32 $21.50
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 91 $14.95
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 22 $12.91
J1815 Injection, insulin, per 5 units <1% 149 $12.65
87340 <1% 12 $6.04
80076 <1% 13 $3.99
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 12 $3.93
J1630 Injection, haloperidol, up to 5 mg <1% 18 $3.35
Q9957 Injection, perflutren lipid microspheres, per ml <1% 16 $3.06
82962 <1% 221 $1.36
J7510 Prednisolone oral, per 5 mg <1% 26 $1.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCAVENIA, JANICE (EXEC DIR, REVENUE CYCLE OPERATIONS)
Same official

Other billing entities under MCAVENIA, JANICE

Full network →
ProviderLocationPaid
Health Affiliates, INC.Freehold, NJ$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.